Tabassome Simon

990 total citations · 1 hit paper
16 papers, 310 citations indexed

About

Tabassome Simon is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tabassome Simon has authored 16 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tabassome Simon's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Acute Myocardial Infarction Research (7 papers) and Cardiac Imaging and Diagnostics (3 papers). Tabassome Simon is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Acute Myocardial Infarction Research (7 papers) and Cardiac Imaging and Diagnostics (3 papers). Tabassome Simon collaborates with scholars based in France, United States and United Kingdom. Tabassome Simon's co-authors include José Carlos Nicolau, Kim Fox, Shamir R. Mehta, Wilhelm Ridderstråle, Philippe Gabríel Steg, Anders Himmelmänn, Lawrence A. Leiter, Deepak L. Bhatt, Robert A. Harrington and Marielle Andersson and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Tabassome Simon

14 papers receiving 309 citations

Hit Papers

Ticagrelor in Patients with Stable Coronary Disease and D... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tabassome Simon France 8 243 129 62 55 25 16 310
Marielle Andersson Sweden 6 256 1.1× 142 1.1× 49 0.8× 79 1.4× 16 0.6× 12 317
Shi Wei Yang China 10 247 1.0× 105 0.8× 25 0.4× 57 1.0× 10 0.4× 15 357
T Ammaturo Italy 5 175 0.7× 199 1.5× 32 0.5× 61 1.1× 22 0.9× 6 312
Athanasios Samaras Greece 12 397 1.6× 52 0.4× 43 0.7× 24 0.4× 23 0.9× 54 474
Sara Lightowlers United Kingdom 6 121 0.5× 52 0.4× 44 0.7× 21 0.4× 31 1.2× 16 238
José María Cepeda Spain 11 139 0.6× 111 0.9× 44 0.7× 10 0.2× 39 1.6× 26 285
Ki Yung Boo South Korea 10 329 1.4× 29 0.2× 24 0.4× 44 0.8× 9 0.4× 27 411
Mahn‐Won Park South Korea 14 330 1.4× 201 1.6× 46 0.7× 44 0.8× 15 0.6× 57 419
Renzo Laborante Italy 10 177 0.7× 49 0.4× 24 0.4× 27 0.5× 3 0.1× 36 237
Dmitry Zamoryakhin United States 10 335 1.4× 38 0.3× 18 0.3× 97 1.8× 13 0.5× 11 459

Countries citing papers authored by Tabassome Simon

Since Specialization
Citations

This map shows the geographic impact of Tabassome Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tabassome Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tabassome Simon more than expected).

Fields of papers citing papers by Tabassome Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tabassome Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tabassome Simon. The network helps show where Tabassome Simon may publish in the future.

Co-authorship network of co-authors of Tabassome Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Tabassome Simon. A scholar is included among the top collaborators of Tabassome Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tabassome Simon. Tabassome Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Prochaska, Micah T., Maria M. Brooks, Dean Fergusson, et al.. (2025). Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia. JAMA Internal Medicine. 185(8). 947–947. 1 indexed citations
2.
Carson, Jeffrey, Dean Fergusson, Helaine Noveck, et al.. (2024). Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Chassany, Olivier, Claire Le Jeunne, Isabelle Borget, et al.. (2024). Methodological expectations for demonstration of health product effectiveness by observational studies. Therapies. 80(1). 47–59.
4.
5.
Laviolle, Bruno, Xavier Anglaret, Jéhan‐Michel Béhier, et al.. (2022). Outpatient healthcare and clinical trials in the care pathway: Organisational and regulatory aspects and tools. Therapies. 77(1). 37–48.
6.
Bagai, Akshay, Faeez Mohamad Ali, John Gregson, et al.. (2022). Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry. Clinical Cardiology. 45(12). 1277–1286. 8 indexed citations
7.
Russo, Juan, Andrew T. Yan, Stuart Pocock, et al.. (2021). Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry. Journal of Cardiology. 79(4). 522–529. 2 indexed citations
8.
Carnicelli, Anthony, Ruth Owen, Stuart Pocock, et al.. (2021). Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. Open Heart. 8(2). e001726–e001726. 3 indexed citations
9.
Fartoukh, Muriel, Alexandre Demoule, Olivier Sanchez, et al.. (2021). Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance. BMJ Open Respiratory Research. 8(1). e000949–e000949. 14 indexed citations
10.
Steg, Philippe Gabríel, Deepak L. Bhatt, Stephanie James, et al.. (2020). Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective. European Heart Journal. 41(Supplement_2). 1 indexed citations
11.
Pocock, Stuart, David Brieger, John Gregson, et al.. (2019). A NOVEL APPROACH TO QUANTIFYING RISK OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS 1-3 YEARS POSTMYOCARDIAL INFARCTION: INSIGHTS FROM THE GLOBAL PROSPECTIVE TIGRIS REGISTRY. Journal of the American College of Cardiology. 73(9). 83–83. 1 indexed citations
12.
Bhatt, Deepak L., Kim Fox, Robert A. Harrington, et al.. (2019). Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical Cardiology. 42(5). 498–505. 14 indexed citations
13.
Steg, Philippe Gabríel, Deepak L. Bhatt, Tabassome Simon, et al.. (2019). Ticagrelor in Patients with Stable Coronary Disease and Diabetes. New England Journal of Medicine. 381(14). 1309–1320. 204 indexed citations breakdown →
14.
Pocock, Stuart, David Brieger, John Gregson, et al.. (2019). Predicting risk of cardiovascular events 1 to 3 years post‐myocardial infarction using a global registry. Clinical Cardiology. 43(1). 24–32. 18 indexed citations
15.
Bourcigaux, Nathalie, Corrado Rubino, Bruno Donadille, et al.. (2018). Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma. Human Reproduction. 33(8). 1408–1416. 19 indexed citations
16.
Westermann, Dirk, Shaun G. Goodman, José Carlos Nicolau, et al.. (2017). Rationale and design of the long‐Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post–myocardial infarction patients (TIGRIS) study. Clinical Cardiology. 40(12). 1197–1204. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026